Jatin Shah - EVP, Chief Medical Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Medical Officer
Issuer Symbol
KPTI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jatin Shah since 13 Mar 2025

Holdings reported by Jatin Shah for Karyopharm Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 129,450 $106,149 $0.8200 17 Feb 2022 Direct

Transactions reported by Jatin Shah for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.